The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ADIZEM-XL 300 mg prolonged release capsules

Mundipharma Pharmaceuticals LimitedPA1688/001/007

Main Information

Trade NameADIZEM-XL 300 mg prolonged release capsules
Active SubstancesDiltiazem hydrochloride
Dosage FormProlonged-release capsule, hard
Licence HolderMundipharma Pharmaceuticals Limited
Licence NumberPA1688/001/007

Group Information

ATC CodeC08DB Benzothiazepine derivatives
C08DB01 diltiazem


License statusAuthorised
Licence Issued16/12/1994
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back